한국지질동맥경화학회 학술대회

Evolving LDL-C management: guidelines and the role of evolocumab

Is LDL-C goal attainment enough? pitavastatin/fenofibrate in mixed dyslipidemia

Bridging guidelines and practice: strategic implementation of combination therapy in lipid management

Paving the road for optimal LDL-C management: new evidence on intensive LDL-C targeting from the Ez-PAVE trial

The role of DPP-4 inhibitors in Korean diabetes care: focusing on K-evidence

The smaller the better: rovazet

Start early: upfront combination therapy for faster LDL-C goal attainment in the CKM era

Start strong: elevating LDL-C management in ASCVD with high-dose atorvastatin plus ezetimibe

Beyond the statin, ROSUZET; start early, switch now

Be the standard ROSUZET; evidence-driven lipid management

Integrated management of hypertension and dyslipidemia for cardiovascular disease prevention

Management of inadequately controlled patients with diabetes mellitus

Protecting the vulnerable period: early and sustained LDL-C control with inclisiran

Proven in the real world: consistent LDL-C control with inclisiran

Clinical updates in dyslipidemia: positioning baroezet for optimal patient care

Strategies for high-risk dyslipidemia patients focusing on ASCVD

Statin therapy strategies for newly diagnosed dyslipidemia patients in clinical practice

Low-dose atorvastatin: addressing an unmet clinical need

The role of low-dose fenofibrate in the management of dyslipidemia

A new oral LDL-C lowering agent with proven CV benefit: bempedoic acid

Integrated lipid management across the CKM spectrum: from evidence to practice

Making vaccination routine for patients with cardiovascular disease

Why is LDL-C control still insufficient? finding the breakthrough with leqvio cases in the aLLT era

Making vaccination routine for patients with cardiovascular disease

New paradigm of initial therapy for hypertension: which patients benefit from amoprel?

Combination treatment in hypertension: why is losartan-based therapy effective?

Cutting-edge care of pitavastatin with ezetimibe combination therapy

Beyond LDL-C reduction comprehensive lipid control in DM patients